Featured news from NHIVNA

HIV-related news from NAM

Dose-finding trials of antibody-based drugs for HIV prevention will start soon
Gus Cairns, 2016-02-24 00:10:00

The next generation of pre-exposure prophylaxis (PrEP), and even of HIV treatment, may consist of antibodies that could be given as an intravenous infusion or an injection into muscle, two presenters at the Conference on Retroviruses and Opportunistic Infections (CROI 2016) in Boston said.

John Mascola of the US national Vaccine Research Centre was presenting at the main conference this morning and Kathryn Stephenson of Harvard Medical School spoke to the Community Cure Research Symposium that happened before the main conference on Sunday. Mascola looked mainly at the potential for antibodies to act as the next generation of PrEP, with a nod to treatment, while Stephenson looked at their potential for forming part of a cure for HIV.